Photodynamic Therapy of Actinic Keratoses With Alacare®

This study aims to collect data on the frequency of SCCs in the Alacare®-treated area during an interval of two years after Alacare®-PDT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Actinic Keratosis Keratosis Keratosis, Actinic Neoplasms Precancerous Conditions Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medizinisches Zentrum Bonn Friedensplatz, Bonn, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Written informed consent
Patients with 3 to 6 mild AK lesions on the hairless areas of the head and face which were treated with Alacare®-PDT according to the SPC

Treatment and study plan

Primary outcomes

Number of SCCs in areas treated with Alacare®-PDT

Time frame: Two years after Alacare®-PDT

Sponsors and collaborators

Lead sponsor

photonamic GmbH & Co. KG

Industry

Registry information

Official study title

Non-interventional Observational Study on Photodynamic Therapy of Actinic Keratoses With Alacare®

Important dates

Study start: 2012
Primary completion: 2016
Study completion: 2016
First posted: Apr 5, 2012
Registry last updated: Sep 27, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed